Comparison of the effect of positive and negative oral contrast agents on 18F-FDG PET/CT scan

Hellenic Journal of Nuclear Medicine

Volumn 12, Issue 2, 2009, Pages

  Sun, Xiao Guang ^a   Huang, Gang ^a   Liu, Jian Jun ^a   Wan, Liang Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

18F fluorodeoxyglucose; Comparison; Gastrointestinal tract; Oral contrast agents; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; MANNITOL; MEGLUMINE DIATRIZOATE; WATER;

ADULT; ARTICLE; BRAIN TUMOR; BREAST CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KRUSKAL WALLIS TEST; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PHYSICIAN; RANK SUM TEST; STUDENT T TEST; VERNER MORRISON SYNDROME;

ADMINISTRATION, ORAL; CONTRAST MEDIA; DIATRIZOATE MEGLUMINE; FEMALE; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MANNITOL; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WATER;

EID: 69249164195     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Dizendorf E, Hany TF, Buck A et al. Cause and Magnitude of the Error Induced by Oral CT Contrast Agent in CT-Based Attenuation Correction of PET Emission Studies. J Nucl Med 2003; 44: 732-738. (Pubitemid 39655207)
2. Cohade C, Osman M, Nakamoto Y et al. Initial Experience with Oral Contrast in PET/CT: Phantom and Clinical Studies. J Nucl Med 2003; 44: 412-416. (Pubitemid 39586018)
3. nd Med Univ 2005; 25: 1253-1256.
4. Otsuka H, Kubo A, Graham M, Nishitani H. The relationship between standard uptake value (SUV) and Hounsfield Unit (HU) of oral contrast agent for FDG-PETZCT study. J Med Invest 2004; 51: 226-229. (Pubitemid 39610918)
5. Otsuka H, Graham MM, Kubo A, Nishitani H. The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 2005; 19: 101-108. (Pubitemid 40745692)
6. Antoch G, Kuehl H, Kanja J et al. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 2004; 230: 879-885. (Pubitemid 38252890)